![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 34, 31486-31494, August 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-Antitrypsin, a Post-Golgi Secretory Pathway Marker, in INS-1 Pancreatic Beta Cells*

From the Division of Endocrinology and Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461
A sulfated
1-antitrypsin (AAT), thought to be a default
secretory pathway marker, is not stored in secretory granules when expressed
in neuroendocrine PC12 cells. In search of a constitutive secretory pathway
marker for pancreatic beta cells, we produced INS-1 cells stably expressing
wild-type AAT. Because newly synthesized AAT arrives very rapidly in the Golgi
complex, kinetics alone cannot resolve AAT release via distinct secretory
pathways, although most AAT is secreted within a few hours and virtually none
is stored in mature granules. Nevertheless, from pulse-chase analyses, a major
fraction of newly synthesized AAT transiently exhibits secretogogue-stimulated
exocytosis and localizes within immature secretory granules (ISGs). This
trafficking occurs without detectable AAT polymerization or binding to lipid
rafts. Remarkably, in a manner not requiring its glycans, all of the newly
synthesized AAT is then removed from granules during their maturation, leading
mostly to constitutive-like AAT secretion, whereas a smaller fraction
(
10%) goes on to lysosomes. Secretogogue-stimulated ISG exocytosis
reroutes newly synthesized AAT directly into the medium and prevents its
arrival in lysosomes. These data are most consistent with the idea that
soluble AAT abundantly enters ISGs and then is efficiently relocated to the
endosomal system, from which many molecules undergo constitutive-like
secretion while a smaller fraction advances to lysosomes.
Received for publication, May 30, 2003
* This work was supported by National Institutes of Health Grant DK48280, an American Diabetes Association mentor-based postdoctoral award, and a grant from the AlphaOne Foundation (all to P. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Division of Endocrinology,
University of Michigan, MSRB2 Rm. 5560, 1500 W. Medical Center Dr., Ann Arbor,
MI 48109. Tel.: 734-936-5505; Fax: 734-651-4499; E-mail:
parvan{at}umich.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Lara-Lemus, M. Liu, M. D. Turner, P. Scherer, G. Stenbeck, P. Iyengar, and P. Arvan Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell J. Cell Sci., May 1, 2006; 119(9): 1833 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Mulcahy, C. A. Vaslet, and E. A. Nillni Prohormone-Convertase 1 Processing Enhances Post-Golgi Sorting of Prothyrotropin-releasing Hormone-derived Peptides J. Biol. Chem., December 2, 2005; 280(48): 39818 - 39826. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Marzban, G. Trigo-Gonzalez, and C. B. Verchere Processing of Pro-Islet Amyloid Polypeptide in the Constitutive and Regulated Secretory Pathways of {beta} Cells Mol. Endocrinol., August 1, 2005; 19(8): 2154 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kuliawat, E. Kalinina, J. Bock, L. Fricker, T. E. McGraw, S. R. Kim, J. Zhong, R. Scheller, and P. Arvan Syntaxin-6 SNARE Involvement in Secretory and Endocytic Pathways of Cultured Pancreatic {beta}-Cells Mol. Biol. Cell, April 1, 2004; 15(4): 1690 - 1701. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |